Shadman Zhaleh, Taleban Forough Azam, Saadat Navid, Hedayati Mehdi
Cellular and Molecular Endocrine Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
J Diabetes Metab Disord. 2013 Jul 20;12(1):42. doi: 10.1186/2251-6581-12-42.
The healthy properties of conjugated linoleic acid (CLA) such as weight loss, reducing cardiovascular risk factors and inflammation have been reported. The trans-10, cis-12 CLA isomer is related to increasing insulin resistance, but the effects of cis-9, trans-11 isomer is not clear. The aim of this study was to investigate the effects of CLA with and without Vitamin E on body weight, body composition, glycemic index, inflammatory and coagulation factors, lipid profile, serum leptin and adiponectin, malondialdehyde (MDA), and blood pressure in type2 diabetes.
56 patients with type2 diabetes were included in 8 week double-blind control trial that used metformin. They randomly divided into three groups: CLA + VitE, CLA + VitE placebo, CLA placebo + VitE placebo. All variables, anthropometric measurements, and body composition were evaluated at the beginning and the end of study. Statistical analysis and analysis of dietary data were performed using SPSS and nutritionist IV software, respectively.
There were not any significant differences in variable changes among three groups. However, there was a trend to increase in MDA and decrease in apoB100 among CLA consumers.
The results of this study showed that administration of CLA supplementation for 8 weeks does not affect any indicators of metabolic control in overweight type2 diabetic patients.
共轭亚油酸(CLA)的健康特性已有报道,如减肥、降低心血管危险因素和炎症。反式-10,顺式-12 CLA异构体与胰岛素抵抗增加有关,但顺式-9,反式-11异构体的作用尚不清楚。本研究的目的是调查补充CLA(无论是否添加维生素E)对2型糖尿病患者体重、身体成分、血糖指数、炎症和凝血因子、血脂谱、血清瘦素和脂联素、丙二醛(MDA)以及血压的影响。
56例2型糖尿病患者参与了一项为期8周的使用二甲双胍的双盲对照试验。他们被随机分为三组:CLA + 维生素E组、CLA + 维生素E安慰剂组、CLA安慰剂 + 维生素E安慰剂组。在研究开始和结束时评估所有变量、人体测量指标和身体成分。分别使用SPSS软件和营养师IV软件进行统计分析和饮食数据的分析。
三组之间的变量变化没有任何显著差异。然而,CLA服用者中MDA有升高趋势,载脂蛋白B100有降低趋势。
本研究结果表明,对超重的2型糖尿病患者补充CLA 8周不会影响任何代谢控制指标。